Gara Jalqabaatti › Glioma › North Carolina › Durham
Qorannoo klinikaalii Glioma Durham, NC keessatti
Qorannoo 12 Glioma f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Medical Center, Durham
Targeted Pediatric High-Grade Glioma Therapy
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Namoota walitti qabaa jiraSadarkaa 3
- Duke Cancer Institute, Durham
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Namoota walitti qabaa jiraSadarkaa 2
- Duke Cancer Center, Durham
Lerapolturev (PVSRIPO) in GBM
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Medical Center, Durham
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Health System, Durham
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Namoota walitti qabaa jiraSadarkaa 1
- Duke University, Durham
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
- Duke University Health System, Durham
Qorannoo Glioma magaalota biroo keessatti
- New York City, NYQorannoo 25
- Houston, TXQorannoo 23
- Boston, MAQorannoo 20
- Washington, DCQorannoo 19
- Philadelphia, PAQorannoo 16
- Columbus, OHQorannoo 15
- Miami, FLQorannoo 15
- San Francisco, CAQorannoo 14
- Chicago, ILQorannoo 13
- Seattle, WAQorannoo 11
- Los Angeles, CAQorannoo 10
- St. Louis, MOQorannoo 10
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 63
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Kansara MetastatikiiQorannoo 33
- Leukemia Myeloidii HamaaQorannoo 33
- Dhibee QaraQorannoo 32
- Kansarii ProstateQorannoo 32
- Kansarii ColorectalQorannoo 28
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Kansarii OvariiQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.